Dose response of repaglinide in patients with newly diagnosed type 2 diabetes: Effect on B-cell secretion

被引：0
|
作者：
Dunseath, GJ
Luzio, SD
Cozma, L
Owens, DR
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
391
引用
收藏
页码：A96 / A96
页数：1
相关论文
共 50 条
  • [11] Association of a SLC30A8 Genetic Variant with Monotherapy of Repaglinide and Rosiglitazone Effect in Newly Diagnosed Type 2 Diabetes Patients in China
    Jiang Feng
    Li Qing
    Hu Cheng
    Zhang Rong
    Wang Cong Rong
    Yu Wei Hui
    Lu Jing Yi
    Tang Shan Shan
    Bao Yu Qian
    Xiang Kun San
    Jia Wei Ping
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2012, 25 (01) : 23 - 29
  • [12] Prediction of treatment response in patients with newly diagnosed type 2 diabetes: the Skaraborg diabetes register
    Pikkemaat, Miriam
    Melander, E.
    Hjerpe, Per
    Bostrom, Kristina Bengtsson
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (05) : 854 - 858
  • [13] Variants of GCKR Affect Both β-Cell and Kidney Function in Patients With Newly Diagnosed Type 2 Diabetes The Verona Newly Diagnosed Type 2 Diabetes Study 2
    Bonetti, Sara
    Trombetta, Maddalena
    Boselli, Maria Linda
    Turrini, Fabiola
    Malerba, Giovanni
    Trabetti, Elisabetta
    Pignatti, Pier Franco
    Bonora, Enzo
    Bonadonna, Riccardo C.
    DIABETES CARE, 2011, 34 (05) : 1205 - 1210
  • [14] Comparison of insulin secretion and sensitivity in subcategories of newly diagnosed type 2 diabetes in Chinese patients
    Dong, YH
    Nan, HR
    Tang, B
    Gao, WG
    DIABETES, 2005, 54 : A620 - A620
  • [15] Prognosis for residual islet β-cell secretion function in young patients with newly diagnosed type 1 diabetes
    Miao, Haitao
    Zhang, Juanjuan
    Gu, Bin
    Gao, Aibo
    Hong, Jie
    Zhang, Yifei
    Gu, Weigiong
    JOURNAL OF DIABETES, 2019, 11 (10) : 818 - 825
  • [16] Effect of repaglinide and gliclazide on glycaemic control, early-phase insulin secretion and lipid profiles in newly diagnosed type 2 diabetics
    Zhang Hong
    Bu Ping
    Xie Yan-hong
    Luo Juan
    Lei Min-xiang
    Mo Zhao-hui
    Liao Er-yuan
    CHINESE MEDICAL JOURNAL, 2011, 124 (02) : 172 - 176
  • [17] Effect of repaglinide and gliclazide on glycaemic control,early-phase insulin secretion and lipid profiles in newly diagnosed type 2 diabetics
    ZHANG Hong
    BU Ping
    XIE Yan-hong
    LUO Juan
    LEI Min-xiang
    MO Zhao-hui
    LIAO Er-yuan
    中华医学杂志（英文版）, 2011, (02) : 172 - 176
  • [18] Hypercortisolism in Newly Diagnosed Type 2 Diabetes: A Prospective Study of 384 Newly Diagnosed Patients
    Steffensen, Charlotte
    Dekkers, Olaf M.
    Lyhne, Johanne
    Pedersen, Bodil G.
    Rasmussen, Finn
    Rungby, Jorgen
    Poulsen, Per Logstrup
    Jorgensen, Jens Otto Lunde
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (01) : 62 - 68
  • [19] Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes
    Owens, DR
    Luzio, SD
    Ismail, I
    Bayer, T
    DIABETES CARE, 2000, 23 (04) : 518 - 523
  • [20] Weight history of patients with newly diagnosed Type 2 diabetes
    Olivarius, N. de Fine
    Richelsen, B.
    Siersma, V.
    Andreasen, A. H.
    Beck-Nielsen, H.
    DIABETIC MEDICINE, 2008, 25 (08) : 933 - 941
12345